Medically Reviewed Protocol | Facility (KR-03481) | Professional Use Only
Lipo Lab PPC Fat Dissolving Solution
Pharmaceutical-grade lipolytic formula engineered for targeted subcutaneous adipose tissue reduction. Utilizes a dual-action mechanism: 98% Sodium Deoxycholate (NaDC) compromises adipocyte cell membranes, while 99.8% Phosphatidylcholine (PPC) emulsifies released intracellular lipids for lymphatic clearance. Formulated without parabens; stabilized with 0.01% Benzyl Alcohol.
Efficacy & Pharmacokinetics
• Adipose Reduction: Averages 1-3mm fat layer thickness reduction per session via ultrasonographic measurement.
• Clearance Rate: 72-hour primary cellular clearance mechanism via macrophage phagocytosis.
• Metabolic Pathway: Hepatic metabolization; requires adequate hydration (2L/day) post-treatment.
Product Specifications
• Volume: 10ml per sterile; 10 per box.
• Active API: PPC (99.8% purity, German-sourced), NaDC (98% purity, Japan-sourced).
• Stability: 24-month shelf life. Store at 2°C–25°C. Avoid direct UV exposure.
• pH Level: Balanced at 7.4 to minimize injection site discomfort.
Indicated Treatment Zones
✔ Submental Area: Localized double chin reduction.
✔ Truncal Adiposity: Abdominal wall, flanks, and bra-line fat.
✔ Extremities: Inner/outer thighs, upper arm (triceps area).
✔ Gynecomastia: Pseudo-gynecomastia fat management.
Practitioner Administration Guidelines
Notice: Protocol parameters are strictly for use by licensed aesthetic medicine professionals.
Gauge: 27G ½” or 30G ½”.
Insertion Angle: 45° to 90°, ensuring intra-adipose delivery (depth: 6-13mm based on tissue thickness).
Spacing: 1.0cm – 1.5cm grid pattern.
Dose per Point: 0.2cc – 0.4cc maximum.
Maximum Dosage: 2 to 5 per session (max 50ml), dependent on patient BMI.
Interval: 14 to 21 days between sessions. 3 to 5 sessions recommended.
Contraindications & Safety Profiling
Contraindications: Hepatic impairment, renal dysfunction, thyroid disorders, autoimmune diseases, pregnancy, and lactation. Not a substitute for bariatric surgery. Not indicated for overall weight loss.
Expected Adverse Events (AEs): Transient erythema (redness), localized edema (swelling) lasting 3-5 days, ecchymosis (bruising), and mild induration at the injection site. Incidence of nodule formation is <0.5% when injected at the correct tissue depth.
Post-Procedure: Mechanical lymphatic massage highly recommended 48 hours post-injection to facilitate lipid clearance.

Reviews
There are no reviews yet.